JPRN-jRCT1042180138招募中2 期
A randomized phase II study to evaluate quality of life after total gastrectomy using a linear stapler vs a circular stapler for esophagojejunostomy
Terashima Masanori0 个研究点目标入组 50 人开始时间: 2019年3月28日最近更新:
适应症
试验速览
- 阶段
- 2 期
- 状态
- 招募中
- 发起方
- 入组人数
- 50
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional
入排标准
- 年龄范围
- >= 20age old 至 ot applicable（—）
- 性别
- All
入选标准
- •1. Histologically proven adenocarcinoma of the stomach
- •2. A total gastrectomy with curative intention is planned for gastric cancer located in the upper third of the stomach.
- •3. cStage I-III
- •4. No esophageal invasion >3 cm
- •5. No gastric stump cancer
- •6. 20-year-old or older
- •7. Eastern cooperative oncology group performance status is 0 or 1.
- •8. No previous chemotherapy or radiation therapy, including those for other cancers
- •9. Body mass index is less than 30.
- •10. Fulfills all of the following conditions
- •WBC>3,000/mm3
- •Plt>100,000/mm3
- •AST<100IU/L
- •ALT<100IU/L
- •T.Bil<2.0g.dl
- •Cre<1.5mg/dl
- •11. Written informed consent
排除标准
- •1. Other active cancer
- •2. Active infectious disease
- •3. Possibly pregnant, or breast feeding woman
- •4. Psychiatric disorder
- •5. Receiving steroids
- •6. Acute myocardial infarction within 6 months or unstable angina
- •7. Uncontrolled hypertension
- •8. Uncontrolled diabetes mellitus and receiving insulin treatment
- •9. Pulmonary disease requiring continuous oxygen therapy
研究者
相似试验
招募中
2 期
A randomized phaseII study to evaluate quality of life after total gastrectomy using a linear stapler vs a circular stapler for esophagojejunostomyGastric cancerJPRN-UMIN000023464Shizuoka Cancer Center50
已完成
2 期
A randomized phase II study for the evaluation of T cell depleted non-myeloablative allogeneic stem cell transplantation followed by early consolidation with lenalidomide or lenalidomide combined with bortezomib and subsequent DLI for patients with multiple myeloma in progression or relapse following first line therapyKahlers disease10035227Multiple MyelomaNL-OMON36688HOVO110
进行中（未招募）
不适用
/ASubjects affected by non-segmental vitiligoMedDRA version: 14.1Level: PTClassification code 10062080Term: Pigmentation disorderSystem Organ Class: 10040785 - Skin and subcutaneous tissue disordersEUCTR2011-000169-10-ITCLINUVEL PHARMACUETICALS LTD.60
进行中（未招募）
1 期
A study to assess the schemas of retreatment with Lutathera® in patients with new progression of intestinal well-differentiated neuroendocrine tumor.EUCTR2021-001306-30-FRInstitut Régional du Cancer de Montpellier146
进行中（未招募）
不适用
A phase II, open, controlled study to evaluate the reactogenicity and the immunogenicity of GlaxoSmithKline Biologicals AS25 adjuvanted influenza vaccine (FluAS25) in elderly adults (=67 years) previously vaccinated in the FluAS25-014 clinical trial with the same candidate vaccine. Fluarix™ (known as a-Rix® in Belgium) will be used as reference. - FluAS25-018 EXT 001 Y3Immunization against influenza in male and female subjects aged 67 years and older.EUCTR2007-002881-36-BEGlaxoSmithKline Biologicals74